Calcium Fructoborate
A plant-style boron-carbohydrate complex studied mainly for knee discomfort. Two small trials from the ingredient's developers reported symptom relief; nobody has independently replicated them.
Evidence last reviewed: August 2026
What the science says
- Knee discomfort Limited evidence
A double-blind, placebo-controlled study in subjects with knee discomfort found that 110 mg twice daily reduced WOMAC and McGill pain scores by day 14, with no change in the placebo group. The study was short, small, and conducted by the ingredient manufacturer.
- Inflammatory markers Limited evidence
A double-blind placebo-controlled pilot study in middle-aged people with primary osteoarthritis reported reductions in CRP and some lipid markers. It was explicitly a pilot with a small sample, and the biomarker changes were not linked to clinical outcomes.
- Compared with established joint supplements Limited evidence
Calcium fructoborate has not been tested head-to-head against glucosamine, chondroitin or NSAIDs in any published trial. All the human evidence traces back to two related research groups.
Dosage & safety
Scientific references
- Short-term efficacy of calcium fructoborate on subjects with knee discomfort: a comparative, double-blind, placebo-controlled clinical study
- A double-blind, placebo-controlled pilot study to evaluate the effect of calcium fructoborate on systemic inflammation and dyslipidemia markers for middle-aged people with primary osteoarthritis
Where to buy
Referral link — this site may earn a commission on purchases.
Related in Joints & skin
- Curcumin (Turmeric extract) Moderate evidence
- Collagen Peptides Moderate evidence
- Glucosamine Limited evidence
- Biotin (Vitamin B7) Limited evidence
- MSM (Methylsulfonylmethane) Limited evidence
- Chondroitin Sulfate Moderate evidence